Biofrontera strengthens commercial focus with reorganization of its US business
January 06, 2020 09:00 ET
|
Biofrontera AG
Leverkusen, Germany, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced a new...
Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera Inc.
December 13, 2019 08:20 ET
|
Biofrontera AG
Leverkusen, Germany, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...